BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 37764202)

  • 1. The Role of
    Pignatelli P; Nuccio F; Piattelli A; Curia MC
    Microorganisms; 2023 Sep; 11(9):. PubMed ID: 37764202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic characterization of outer membrane vesicles from gut mucosa-derived fusobacterium nucleatum.
    Liu J; Hsieh CL; Gelincik O; Devolder B; Sei S; Zhang S; Lipkin SM; Chang YF
    J Proteomics; 2019 Mar; 195():125-137. PubMed ID: 30634002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Porphyromonas gingivalis outer membrane vesicles inhibit the invasion of Fusobacterium nucleatum into oral epithelial cells by downregulating FadA and FomA.
    Zhang Z; Liu S; Zhang S; Li Y; Shi X; Liu D; Pan Y
    J Periodontol; 2022 Apr; 93(4):515-525. PubMed ID: 34458990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative Analysis of Colon Cancer-Derived Fusobacterium nucleatum Subspecies: Inflammation and Colon Tumorigenesis in Murine Models.
    Queen J; Domingue JC; White JR; Stevens C; Udayasuryan B; Nguyen TTD; Wu S; Ding H; Fan H; McMann M; Corona A; Larman TC; Verbridge SS; Housseau F; Slade DJ; Drewes JL; Sears CL
    mBio; 2021 Feb; 13(1):e0299121. PubMed ID: 35130731
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Hussan H; Clinton SK; Roberts K; Bailey MT
    World J Gastroenterol; 2017 Dec; 23(48):8626-8650. PubMed ID: 29358871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of
    Sun CH; Li BB; Wang B; Zhao J; Zhang XY; Li TT; Li WB; Tang D; Qiu MJ; Wang XC; Zhu CM; Qian ZR
    Chronic Dis Transl Med; 2019 Sep; 5(3):178-187. PubMed ID: 31891129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative Proteomic Analysis of Outer Membrane Vesicles from Fusobacterium nucleatum Cultivated in the Mimic Cancer Environment.
    Zhang X; Wang Y; Fan R; Zhang L; Li Z; Zhang Y; Zheng W; Wang L; Liu B; Quan C
    Microbiol Spectr; 2023 Aug; 11(4):e0039423. PubMed ID: 37341631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carcinogenesis mechanisms of Fusobacterium nucleatum.
    Gholizadeh P; Eslami H; Kafil HS
    Biomed Pharmacother; 2017 May; 89():918-925. PubMed ID: 28292019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fusobacterium nucleatum and oral cancer: a critical review.
    McIlvanna E; Linden GJ; Craig SG; Lundy FT; James JA
    BMC Cancer; 2021 Nov; 21(1):1212. PubMed ID: 34774023
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Engevik MA; Danhof HA; Ruan W; Engevik AC; Chang-Graham AL; Engevik KA; Shi Z; Zhao Y; Brand CK; Krystofiak ES; Venable S; Liu X; Hirschi KD; Hyser JM; Spinler JK; Britton RA; Versalovic J
    mBio; 2021 Mar; 12(2):. PubMed ID: 33653893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fusobacterium nucleatum and colorectal cancer: A mechanistic overview.
    Hashemi Goradel N; Heidarzadeh S; Jahangiri S; Farhood B; Mortezaee K; Khanlarkhani N; Negahdari B
    J Cell Physiol; 2019 Mar; 234(3):2337-2344. PubMed ID: 30191984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fecal Fusobacterium nucleatum harbored virulence gene fadA are associated with ulcerative colitis and clinical outcomes.
    Li DH; Li ZP; Yan Zhang ; Zhou GZ; Ren RR; Zhao HJ; Zhang NN; Li JF; Peng LH; Yang YS
    Microb Pathog; 2021 Aug; 157():104964. PubMed ID: 34022363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fusobacterium nucleatum Contributes to the Carcinogenesis of Colorectal Cancer by Inducing Inflammation and Suppressing Host Immunity.
    Wu J; Li Q; Fu X
    Transl Oncol; 2019 Jun; 12(6):846-851. PubMed ID: 30986689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colon Cancer-Associated
    Abed J; Maalouf N; Manson AL; Earl AM; Parhi L; Emgård JEM; Klutstein M; Tayeb S; Almogy G; Atlan KA; Chaushu S; Israeli E; Mandelboim O; Garrett WS; Bachrach G
    Front Cell Infect Microbiol; 2020; 10():400. PubMed ID: 32850497
    [No Abstract]   [Full Text] [Related]  

  • 15. Outer Membrane Vesicles From
    Chen G; Sun Q; Cai Q; Zhou H
    Front Microbiol; 2022; 13():815638. PubMed ID: 35391731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Roles and Interactions of
    Wang B; Deng J; Donati V; Merali N; Frampton AE; Giovannetti E; Deng D
    Pathogens; 2024 Jan; 13(1):. PubMed ID: 38276166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conversion from epithelial to partial-EMT phenotype by Fusobacterium nucleatum infection promotes invasion of oral cancer cells.
    Shao W; Fujiwara N; Mouri Y; Kisoda S; Yoshida K; Yoshida K; Yumoto H; Ozaki K; Ishimaru N; Kudo Y
    Sci Rep; 2021 Jul; 11(1):14943. PubMed ID: 34294795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fusobacterium nucleatum, a key pathogenic factor and microbial biomarker for colorectal cancer.
    Wang N; Fang JY
    Trends Microbiol; 2023 Feb; 31(2):159-172. PubMed ID: 36058786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FadA promotes DNA damage and progression of Fusobacterium nucleatum-induced colorectal cancer through up-regulation of chk2.
    Guo P; Tian Z; Kong X; Yang L; Shan X; Dong B; Ding X; Jing X; Jiang C; Jiang N; Yu Y
    J Exp Clin Cancer Res; 2020 Sep; 39(1):202. PubMed ID: 32993749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Fusobacterium nucleatum with immunity and molecular alterations in colorectal cancer.
    Nosho K; Sukawa Y; Adachi Y; Ito M; Mitsuhashi K; Kurihara H; Kanno S; Yamamoto I; Ishigami K; Igarashi H; Maruyama R; Imai K; Yamamoto H; Shinomura Y
    World J Gastroenterol; 2016 Jan; 22(2):557-66. PubMed ID: 26811607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.